Semaglutide FlexTouch Pen

Semaglutide FlexTouch Pen is a prescription GLP-1 receptor agonist delivery device used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is supplied as a prefilled pen for convenient subcutaneous administration. The pen is designed to provide accurate and reliable dose delivery as prescribed.

BUY NOW

Category

Semaglutide FlexTouch Pen contains semaglutide, a GLP-1 receptor agonist that helps regulate blood glucose by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The prefilled pen is engineered for precise subcutaneous dose administration, offering ease of handling and consistent injection performance throughout the treatment period. Manufactured under stringent pharmaceutical quality standards, the sterile pen is intended for single-patient use and supports dependable therapeutic delivery. Semaglutide FlexTouch Pen should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Semaglutide FlexTouch Pen
Active Ingredient Semaglutide
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Dosing Frequency As Prescribed (typically once weekly for injectable semaglutide products)
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Semaglutide FlexTouch Pen, Semaglutide Injection Pen, GLP-1 Receptor Agonist Pen, Semaglutide Prefilled Pen, Diabetes Injection Pen, Weekly Semaglutide Pen, Semaglutide Injectable Pen